Alongside appreciating the nature of growth investing from a risk perspective, Ian Battersby argues it is critical advisers obtain comfort from providers over both deal-flow quality and deployment capability
So the dust is settling in the aftermath of the Patient Capital Review and Enterprise Investment Scheme (EIS) season is in full swing. The future is all about growth companies. It now seems to be accepted...
Staying invested could prove lucrative
Consider lasting powers of attorney
Less environment, more governance threatens to undermine firms' green credentials
Evidence your compliance